SHL Telemedicine Ltd American Depositary Shares (SHLT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SHL Telemedicine Ltd American Depositary Shares (SHLT) has a cash flow conversion efficiency ratio of -0.002x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-173.00K) by net assets ($70.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SHL Telemedicine Ltd American Depositary Shares - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how SHL Telemedicine Ltd American Depositary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SHLT current and long-term liabilities for a breakdown of total debt and financial obligations.
SHL Telemedicine Ltd American Depositary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SHL Telemedicine Ltd American Depositary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jentayu Sustainables Bhd
KLSE:5673
|
-0.071x |
|
Mohenz.Co.Ltd
KQ:006920
|
0.017x |
|
Naos Small Cap Opportunities Company Ltd
AU:NSC
|
0.063x |
|
Dierig Holding AG
XETRA:DIE
|
0.070x |
|
Bio-Works Technologies AB
ST:BIOWKS
|
-0.236x |
|
Wellbiotec Co. Ltd.
KO:010600
|
-0.033x |
|
Camino Minerals Corporation
V:COR
|
-0.025x |
|
TransAct Technologies Incorporated
NASDAQ:TACT
|
0.114x |
Annual Cash Flow Conversion Efficiency for SHL Telemedicine Ltd American Depositary Shares (2002–2024)
The table below shows the annual cash flow conversion efficiency of SHL Telemedicine Ltd American Depositary Shares from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see SHL Telemedicine Ltd American Depositary market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $39.25 Million | $-372.00K | -0.009x | +51.56% |
| 2023-12-31 | $76.46 Million | $-1.50 Million | -0.020x | -1489.07% |
| 2022-12-31 | $59.29 Million | $-73.00K | -0.001x | -140.44% |
| 2021-12-31 | $60.76 Million | $185.00K | 0.003x | -97.54% |
| 2020-12-31 | $37.88 Million | $4.68 Million | 0.124x | -60.42% |
| 2019-12-31 | $34.74 Million | $10.85 Million | 0.312x | -7.74% |
| 2018-12-31 | $37.68 Million | $12.76 Million | 0.338x | -16.52% |
| 2017-12-31 | $29.21 Million | $11.84 Million | 0.405x | +2351.00% |
| 2016-12-31 | $23.82 Million | $-429.00K | -0.018x | -119.28% |
| 2015-12-31 | $42.60 Million | $3.98 Million | 0.093x | +284.04% |
| 2014-12-31 | $61.40 Million | $-3.12 Million | -0.051x | -224.28% |
| 2013-12-31 | $68.91 Million | $2.81 Million | 0.041x | +53.22% |
| 2012-12-31 | $60.99 Million | $1.63 Million | 0.027x | +150.66% |
| 2011-12-31 | $66.56 Million | $-3.50 Million | -0.053x | -230.69% |
| 2010-12-31 | $74.70 Million | $3.01 Million | 0.040x | -50.01% |
| 2009-12-31 | $65.30 Million | $5.26 Million | 0.081x | +163.02% |
| 2008-12-31 | $59.07 Million | $-7.55 Million | -0.128x | -329.31% |
| 2007-12-31 | $60.50 Million | $-1.80 Million | -0.030x | -149.30% |
| 2006-12-31 | $29.81 Million | $1.80 Million | 0.060x | +1284.09% |
| 2005-12-31 | $40.78 Million | $-208.00K | -0.005x | -131.86% |
| 2004-12-31 | $81.52 Million | $1.30 Million | 0.016x | +117.32% |
| 2003-12-31 | $87.56 Million | $645.00K | 0.007x | -69.38% |
| 2002-12-31 | $92.06 Million | $2.21 Million | 0.024x | -- |
About SHL Telemedicine Ltd American Depositary Shares
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company als… Read more